braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastična sredstva - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
mispregnol 400 mikrograma tablete
exelgyn, 216 bd saint-germain, pariz, francuska - mizoprostol - tableta - 400 mikrograma - urbroj: jedna tableta sadrži 400 mikrograma mizoprostola
isoprinosine ewopharma 500 mg tablete
ewopharma international s.r.o., prokopa veľkého 52, bratislava, slovačka - inozin acedoben dimepranol - tableta - 500 mg - urbroj: jedna tableta sadrži 500 mg inozin acedoben dimepranola
isoprinosine ewopharma 50 mg/ml sirup
ewopharma international s.r.o., prokopa veľkého 52, bratislava, slovačka - inozin acedoben dimepranol - sirup - 50 mg/ml - urbroj: 1 ml sirupa sadrži 50,0 mg inozin acedoben dimepranola; jedna žličica (5 ml) sirupa sadrži 250 mg inozin acedoben dimepranola
dipleksil 250 mg želučanootoporne tablete
tecnifar industria tecnica farmaceutica s.a., torre sul, rua josé da costa pedreira 11 b, lisabon, portugal - heminatrijev valproat - Želučanootporna tableta - urbroj: svaka želučanootporna tableta od 250 mg sadrži 269,1 mg heminatrijevog valproata što odgovara 250 mg valproatne kiseline
dipleksil 500 mg želučanootoporne tablete
tecnifar industria tecnica farmaceutica s.a., torre sul, rua josé da costa pedreira 11 b, lisabon, portugal - heminatrijev valproat - Želučanootporna tableta - urbroj: svaka želučanootporna tableta od 500 mg sadrži 538,2 mg heminatrijevog valproata, što odgovara 500 mg valproatne kiseline
firmagon
ferring pharmaceuticals a/s - degarelix - prostatske neoplazme - endokrinska terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
nurofen 200 mg ljekoviti flaster
reckitt benckiser d.o.o., ulica grada vukovara 269d, zagreb, hrvatska - ibuprofen - ljekoviti flaster - 200 mg - urbroj: svaki ljekoviti flaster sadrži 200 mg ibuprofena
adcetris
takeda pharma a/s - Брентуксимаб ведотин - lymphoma, non-hodgkin; hodgkin disease - antineoplastična sredstva - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). Адцетриса indiciran za liječenje odraslih pacijenata s relaps ili vatrostalne cd30+ limfom Ходжкина (ЛХ):nakon terapije, orfollowing barem dva do terapije nakon terapije ili мультиагентной kemoterapije-to nije opcija liječenja . sistem анапластическая крупноклеточная lymphomaadcetris u kombinaciji s ciklofosfamid, doksorubicin i prednizon (chp) je prikazana za odrasle pacijente s prethodno liječenih liječenje sistemske анапластической veliki stanica limfoma (salcl). Адцетриса indiciran za liječenje odraslih pacijenata s relaps ili vatrostalne salcl. kožni t-stanica lymphomaadcetris indiciran za liječenje odraslih bolesnika s cd30+ stanica kožni t limfom (ctcl), nakon što je najmanje 1 do sistemske terapije.
tantum verde 3 mg pastile s okusom limuna
aziende chimiche riunite angelini francesco a.c.r.a.f. s.p.a, via amelia 70, rim, italija - benzidaminklorid - pastila - 3 mg - urbroj: jedna pastila sadrži 3 mg benzidaminklorida